Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes

2017 ◽  
Vol 18 (14) ◽  
pp. 1433-1438 ◽  
Author(s):  
Akio Ohta ◽  
Hiroyuki Kato ◽  
Satoshi Ishii ◽  
Yosuke Sasaki ◽  
Yuta Nakamura ◽  
...  
2017 ◽  
Vol 56 (6) ◽  
pp. 597-604 ◽  
Author(s):  
Takahiro Tosaki ◽  
Hideki Kamiya ◽  
Tatsuhito Himeno ◽  
Yoshiro Kato ◽  
Masaki Kondo ◽  
...  

2011 ◽  
Vol 94 (3) ◽  
pp. 468-470 ◽  
Author(s):  
Motoh Iwasa ◽  
Rumi Mifuji-Moroka ◽  
Nagisa Hara ◽  
Masumi Ishidome ◽  
Kazuko Iwata ◽  
...  

2018 ◽  
Vol 103 (7) ◽  
pp. 2698-2706 ◽  
Author(s):  
Eveline Bruinstroop ◽  
Rinkoo Dalan ◽  
Yang Cao ◽  
Yong Mong Bee ◽  
Kurumbian Chandran ◽  
...  

2016 ◽  
Vol 31 (6) ◽  
pp. 924 ◽  
Author(s):  
Juyoung Han ◽  
So Hun Kim ◽  
Young Ju Suh ◽  
Hyun Ae Lim ◽  
Heekyoung Shin ◽  
...  

2015 ◽  
Vol 109 (1) ◽  
pp. 199-205 ◽  
Author(s):  
Hiroyuki Kato ◽  
Yoshio Nagai ◽  
Akio Ohta ◽  
Ayumi Tenjin ◽  
Yuta Nakamura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document